Hans Theodor Josef Steiger

Dr. Hans Theodor Josef Steiger

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Journal of Instrumentation
Verified
Journal Article
Open access
HSHans Theodor Josef Steiger
Hans Theodor Josef Steiger
MBManuel Böhles
Manuel Böhles
MSMatthias Raphael Stock
Matthias Raphael Stock
MWMichael Wurm
Michael Wurm
DDDavid Dörflinger
David Dörflinger
DZDorina Zundel
Dorina Zundel
Water-based Liquid Scintillator (WbLS) is a novel detector medium for particle physics experiments. Applications range from the use as hybrid Cherenkov/scintillation target in low-energy and accelerator neutrino experiments to large-volume neutron vetoes for dark matter detectors. Here we present a WbLS based on well-known components (the surfactant Triton-X, the fluor PPO and vitamin C for long-term stability), with which a new recipe was developed and the result subjected to a thorough characterization of its properties. In addition, based on neutron scattering data we are able to demonstrate that the pulse shape discrimination capabilities of this particular LS are comparable to all-organic LAB based scintillators.

22 September 2022 in Instruments
Verified
Journal Article
Open access
PDF file
HSHans Theodor Josef Steiger
Hans Theodor Josef Steiger
The Taishan Antineutrino Observatory (TAO or JUNO-TAO) is a satellite detector for the Jiangmen Underground Neutrino Observatory (JUNO). JUNO aims at simultaneously probing the two main frequencies of three-flavor neutrino oscillations, as well as their interference related to the mass ordering, at a distance of ~53 km from two powerful nuclear reactor complexes in China. Located near the Taishan-1 reactor, TAO independently measures the antineutrino energy spectrum of the reactor with unprecedented energy resolution. The TAO experiment will realize a neutrino detection rate of about 2000 per day. In order to achieve its goals, TAO is relying on cutting-edge technology, both in photosensor and liquid scintillator (LS) development which is expected to have an impact on future neutrino and Dark Matter detectors. In this paper, the design of the TAO detector with a special focus on calorimetry is discussed. In addition, an overview of the progress currently being made in the R&D for a photosensor and LS technology in the frame of the TAO project will be presented.

1 April 2019 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Verified
Journal Article
Open access
MSMario Schwarz
Mario Schwarz
SFSabrina M. Franke
Sabrina M. Franke
LOLothar Oberauer
Lothar Oberauer
MPMiriam D. Plein
Miriam D. Plein
HSHans Theodor Josef Steiger
Hans Theodor Josef Steiger
MTMarc Tippmann
Marc Tippmann

1 September 2024 in Journal of Instrumentation
Verified
Journal Article
Open access
HSHans Theodor Josef Steiger
Hans Theodor Josef Steiger
MSMatthias Raphael Stock
Matthias Raphael Stock
MBManuel Böhles
Manuel Böhles
SBSarah Braun
Sarah Braun
ECEdward J. Callaghan
Edward J. Callaghan
DZDorina Zundel
Dorina Zundel
One of the most promising approaches for the next generation of neutrino experiments is the realization of large hybrid Cherenkov/scintillation detectors made possible by recent innovations in photodetection technology and liquid scintillator chemistry. The development of a potentially suitable future detector liquid with particularly slow light emission is discussed in the present publication. This cocktail is compared with respect to its fundamental characteristics (scintillation efficiency, transparency, and time profile of light emission) with liquid scintillators currently used in large-scale neutrino detectors. In addition, the optimization of the admixture of wavelength shifters for a scintillator with particularly high light emission is presented. Furthermore, the pulse-shape discrimination capabilities of the novel medium was studied using a pulsed particle accelerator driven neutron source. Beyond that, purification methods based on column chromatography and fractional vacuum distillation for the co-solvent DIN (Diisopropylnaphthalene) are discussed.

9 February 2026 in Communications Physics
Verified
Journal Article
Open access
PDF file
ACA. Cabrera
A. Cabrera
MCM. Chen
M. Chen
Fabio MantovaniFabio Mantovani
Fabio Mantovani
ASAndrea Serafini
Andrea Serafini
Virginia StratiVirginia Strati
Virginia Strati
FYF. Yermia
F. Yermia
Puzzles exist in our theories of Earth’s formation and bulk chemical composition. Related to these questions is our incomplete knowledge of the planet’s overall heat budget and thermal history. The successful observation of geoneutrinos originating from uranium and thorium decay chains, manifestations of the planet’s natural radioactivity, serves as the only direct probe of Earth’s internal, radiogenic heat engine so far. Intriguingly, potassium (40K) geoneutrinos have never been observed and have so far been considered impractical to measure despite their importance in Earth’s radioactive inventory. We propose here an approach for potassium geoneutrino detection that exploits their antiparticle nature. The detection framework relies on the LiquidO technique to identify positrons, thereby reducing otherwise overwhelming backgrounds. Antineutrino interactions with candidate isotope targets have been thoroughly examined and copper is found to be the ideal isotope able to meet all experimental feasibility conditions. We discuss the challenging experimental requirements to yield a potassium geoneutrino discovery.

27 April 2015 in Journal of Neurological Surgery Part A: Central European Neurosurgery
Verified
Journal Article
Closed access
PDF file
HSHosai Sadat
Hosai Sadat
PSPhilipp Joerg Slotty
Philipp Joerg Slotty
HSHans Theodor Josef Steiger
Hans Theodor Josef Steiger
WBWilfried Budach
Wilfried Budach
MSMichael Sabel
Michael Sabel
MRMarion Rapp
Marion Rapp
Objective With the publication of the European Organization for Research and Treatment of Cancer/National Cancer Information Center (EORTC/NCIC) trial, concomitant radiochemotherapy followed by intermittent chemotherapy became the new treatment standard for patients with primary glioblastoma. Eight years after widespread introduction of this protocol, it is of interest to investigate whether this new standard has been established in daily neuro-oncologic practice. We were particularly interested in its practicality within a neurosurgical neuro-oncologic setting. Patients and Methods We analyzed primary glioblastoma patients diagnosed between 2005 and 2013 treated at our center according to the EORTC/NCIC trial. Parameters associated with treatment performance (interruption of radiotherapy, concomitant chemotherapy and intermittent chemotherapy, total number of cycles, and side effects) were retrospectively analyzed and compared with the available data from the EORTC/NCIC trial. Results In this single-center retrospective study, we identified 189 patients (116 men, 73 women; median age: 62 years) who were treated according to the EORTC/NCIC trial protocol. A total of 176 patients received cytoreductive surgery; 13 patients had stereotactic biopsy only (EORTC/NCIC trial: 239 patients and 48 patients, respectively). Radiotherapy had to be interrupted in 9 patients (5%) (EORTC/NCIC trial: 15 patients [5%]) and concomitant chemotherapy in 26 patients (14%) (EORTC/NCIC trial: 37 patients [13%]). In 156 patients (83%), adjuvant TMZ chemotherapy was initiated (6 median temozolomide [TMZ] cycles; range: 1–30). In the EORTC/NCIC trial, 223 patients (47%) received the intermittent chemotherapy protocol (median: 3 cycles; range: 1–7). Overall, 97 patients (62%) completed 6 TMZ cycles (EORTC/NCIC-trial: 105 patients [47%]); dose escalation to 200 mg/qm at the second cycle was performed in 91 patients (58%) (versus 149 patients [67%]). Intermittent TMZ therapy was discontinued in 59 patients (38%) (versus 118 patients [53%]). Median overall survival in our patient cohort was 19 months (versus 14.6 months); median time to progression was 9 months (versus 6.9 months). Conclusion Comparison between the feasibility of the treatment protocol established by the EORTC/NCIC trial (performed within the setting of a prospective randomized trial) and the daily routine in a dedicated neurosurgical neuro-oncologic department demonstrates that the protocol is suitable for daily practice within a neurosurgical unit.